Results for tag: "Leukocyte Disorders"

The Leukocyte Disorders market is a subset of the Hematology market, which focuses on the diagnosis and treatment of diseases related to the body's white blood cells. Leukocyte Disorders are a group of conditions that affect the production, function, and lifespan of white blood cells. These disorders can be caused by genetic mutations, infections, or other environmental factors. Common symptoms of Leukocyte Disorders include fatigue, fever, and an increased risk of infection. Treatment options vary depending on the type and severity of the disorder, but may include medications, blood transfusions, and stem cell transplants. Companies in the Leukocyte Disorders market include Novartis, Pfizer, Gilead Sciences, and Celgene. Show Less Read more